Major Depression

The US Food and Drug Administration (FDA) has rejected Alkermes’ New Drug Application for ALKS 5461, a proposed adjunctive treatment for major depressive disorder, citing the need for additional clinical data exhibiting its effectiveness.


A mother’s depression is linked with her children's development from infancy through adolescence, according to a new study.